Evolution of the Use of Corticosteroids for the Treatment of Hospitalised COVID-19 Patients in Spain between March and November 2020: SEMI-COVID National Registry
No Thumbnail Available
Identifiers
Date
2021-10-01
Authors
Balaz, David
Erick Wikman-Jorgensen, Philip
Giner Galvan, Vicente
Rubio-Rivas, Manuel
de Miguel Campo, Borja
Noureddine Lopez, Mariam
Lopez Caleya, Juan Francisco
Gomez Huelgas, Ricardo
Pesqueira Fontan, Paula Maria
Mendez Bailon, Manuel
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Mdpi
Metrics
Export
Abstract
Objectives: Since the results of the RECOVERY trial, WHO recommendations about the use of corticosteroids (CTs) in COVID-19 have changed. The aim of the study is to analyse the evolutive use of CTs in Spain during the pandemic to assess the potential influence of new recommendations. Material and methods: A retrospective, descriptive, and observational study was conducted on adults hospitalised due to COVID-19 in Spain who were included in the SEMI-COVID-19 Registry from March to November 2020. Results: CTs were used in 6053 (36.21%) of the included patients. The patients were older (mean (SD)) (69.6 (14.6) vs. 66.0 (16.8) years; p
Description
MeSH Terms
DeCS Terms
CIE Terms
Keywords
COVID-19, corticosteroids, Spain, comorbidities, Sars